Farrow Jeffrey S 4
4 · Tarsus Pharmaceuticals, Inc. · Filed Apr 26, 2023
Insider Transaction Report
Form 4
Farrow Jeffrey S
See Remarks
Transactions
- Award
Stock Option (right to buy)
2023-04-24+163,397→ 163,397 totalExercise: $14.62Exp: 2033-04-23→ Common Stock (163,397 underlying) - Award
Restricted Stock Units
2023-04-24+111,525→ 111,525 total→ Common Stock (111,525 underlying)
Footnotes (3)
- [F1]25% of the option shares shall vest on April 24, 2024, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
- [F3]25% of the RSUs will vest on June 15th of each of 2024, 2025, 2026, and 2027, subject to the Reporting Person's continuous service.